These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15382384)

  • 1. New drugs 04. Part III.
    Hussar DA
    Nursing; 2004 Sep; 34(9):56-62; quiz 63-4. PubMed ID: 15382384
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
    Viale PH
    Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stain wars.
    Jureidini J; Mansfield P; Menkes D
    Lancet; 2003 Nov; 362(9398):1855; discussion 1856. PubMed ID: 14654332
    [No Abstract]   [Full Text] [Related]  

  • 4. The stain wars.
    Blenkinsopp J
    Lancet; 2003 Nov; 362(9398):1854; discussion 1856. PubMed ID: 14654328
    [No Abstract]   [Full Text] [Related]  

  • 5. The statin wars.
    McKillop T
    Lancet; 2003 Nov; 362(9394):1498. PubMed ID: 14602449
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of palonosetron, aprepitant, and dexamethasone as primary antiemetic prophylaxis for cisplatin-based chemotherapy.
    Yang CK; Wu CE; Liaw CC
    Biomed J; 2016 Feb; 39(1):60-6. PubMed ID: 27105599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stain wars.
    Wozniak P
    Lancet; 2003 Nov; 362(9398):1855; discussion 1856. PubMed ID: 14654331
    [No Abstract]   [Full Text] [Related]  

  • 8. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
    Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
    Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of aprepitant and palonosetron on cisplatin doublet in lung cancer].
    Suzuki C; Hiura K; Sato H; Komori H; Yamamoto M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1653-7. PubMed ID: 21996961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA approves a statin therapy for some: certain, asymptomatic individuals targeted.
    Mitka M
    JAMA; 2010 Apr; 303(13):1242-3. PubMed ID: 20371776
    [No Abstract]   [Full Text] [Related]  

  • 11. The stain wars.
    Olsson GO; Blasetto JW; Bryzinski BS; Caplan RJ; Gold A
    Lancet; 2003 Nov; 362(9398):1855-6; discussion 1856. PubMed ID: 14654329
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosuvastatin receives FDA approval.
    Cardiovasc J S Afr; 2003; 14(5):286. PubMed ID: 14664234
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonosetron Versus Aprepitant Plus Ramosetron in Patients at High Risk for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized-controlled Trial.
    Choi EK; Kim DG; Jeon Y
    Surg Laparosc Endosc Percutan Tech; 2016 Oct; 26(5):354-357. PubMed ID: 27636144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing access to myeloma treatment: administration, side effects, and implications for survival.
    Davies MJ
    ONS News; 2006; 21(8 Suppl):11-2. PubMed ID: 16925131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Breast cancer and Her-2].
    Hatake K
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():87-94. PubMed ID: 17682144
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of lipid correcting therapy with the use of rosuvastatin].
    Ivleva AIa
    Kardiologiia; 2005; 45(6):71-80. PubMed ID: 16007037
    [No Abstract]   [Full Text] [Related]  

  • 17. JUPITER, rosuvastatin, and the European Medicines Agency.
    Ridker PM; Glynn RJ
    Lancet; 2010 Jun; 375(9731):2071. PubMed ID: 20494436
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory divergence.
    Breckenridge A
    Clin Trials; 2011 Aug; 8(4):425-6; discussion 430-1. PubMed ID: 21835859
    [No Abstract]   [Full Text] [Related]  

  • 19. New oncology strategy: molecular targeting of cancer cells.
    Capriotti T
    Medsurg Nurs; 2004 Jun; 13(3):191-5. PubMed ID: 15219169
    [No Abstract]   [Full Text] [Related]  

  • 20. Abstracts of the XV International Symposium on Drugs Affecting Lipid Metabolism, 24-27 October, 2004, Venice, Italy.
    Int J Clin Pract Suppl; 2005 Jun; (148):3-16. PubMed ID: 15885073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.